Filter Results:
(6,516)
Show Results For
- All HBS Web
(6,516)
- People (18)
- News (2,151)
- Research (3,585)
- Events (3)
- Multimedia (212)
- Faculty Publications (2,763)
Show Results For
- All HBS Web
(6,516)
- People (18)
- News (2,151)
- Research (3,585)
- Events (3)
- Multimedia (212)
- Faculty Publications (2,763)
- 04 May 2020
- News
In The Age Of Coronavirus, How Doctors Are Becoming Inventors
- 26 Mar 2020
- News
Managing Through Crisis: Let's Talk About Small Business
- May 2008 (Revised July 2012)
- Teaching Note
PSI India -- Will Balbir Pasha Help Fight AIDS? (TN) (A) and (B)
By: Elie Ofek
Teaching Note for [507032] and [507058]. View Details
- 09 Aug 2016
- Blog Post
Startup Balancing Act
It was my first day of work and I was nervous, so much so that my legs were wobbly. I tilted forward, then backward. I finally steadied myself by grabbing onto a cubicle wall and was able to move forward evenly. However, I soon found myself grabbing for the cubicle... View Details
Keywords: Health Care
- 01 Mar 2006
- News
MD/MBA Program Launched
will produce “a new generation of leaders in health care.” Graduates of the program, whose enrollment will increase over time, will be encouraged to practice medicine before becoming senior executives in hospitals, health-care... View Details
- Profile
Maya Babu
contractors and service providers." Encouraged by her mentor at the Administration, Maya applied for the joint MD/MBA degree. Understanding both sides of the health care system To prepare for... View Details
- Article
Incidence and Preventability of Adverse Drug Events in the Nursing Home Setting
By: J. H. Gurwitz, T. S. Field, J. Avorn, D. McCormick, S. Jain, M. Eckler, M. Benser, A. Edmondson and D. W. Bates
Gurwitz, J. H., T. S. Field, J. Avorn, D. McCormick, S. Jain, M. Eckler, M. Benser, A. Edmondson, and D. W. Bates. "Incidence and Preventability of Adverse Drug Events in the Nursing Home Setting." American Journal of Medicine 109, no. 2 (2000): 87–94.
- August 1998
- Article
Critical Pathways at the Massachusetts General Hospital
By: Richard Bohmer
Bohmer, Richard. "Critical Pathways at the Massachusetts General Hospital." Journal of Vascular Surgery 28, no. 2 (August 1998): 373–377.
- Web
Middle East & North Africa - Global Activities 2021
Mission to Improve the Health Care System Nora Rabah (MS/MBA 2022), a fellowship recipient who emigrated from Syria at age five, is a member of the first cohort of the MS/MBA in Biotechnology: Life Sciences... View Details
- 01 Jun 2020
- Working Paper Summaries
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
- Web
Patients - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care View Details
- March 2015 (Revised February 2022)
- Supplement
CV Ingenuity (B): Epilogue
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors?
The... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Strategy; Health Industry; Health Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (B): Epilogue." Harvard Business School Supplement 315-087, March 2015. (Revised February 2022.)
- 21 Dec 2012
- News
Kathy Giusti's Quest for a Cure
- December 2006 (Revised August 2008)
- Case
Pervasis Therapeutics, Inc.
By: Robert F. Higgins and Virginia Fuller
In May 2005, Steve Bollinger was about to become president and chief operating officer of Pervasis Therapeutics, a small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and... View Details
Keywords: Business Startups; Venture Capital; Financial Strategy; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Health Testing and Trials; Health Industry; Cambridge
Higgins, Robert F., and Virginia Fuller. "Pervasis Therapeutics, Inc." Harvard Business School Case 807-026, December 2006. (Revised August 2008.)
- Web
VBHCD Initiative - Institute For Strategy And Competitiveness
HBS ISC About Michael Porter About Michael Porter A Letter from Michael Porter Biography The Essential Porter Honors & Awards Affiliated Organizations & Institutions VBHCD Initiative VBHCD Initiative Cost Measurement Research The Value Based View Details
- Profile
Zayed Muhammed Yasin
support at HBS "Health care is especially complicated," says Zayed. "The MBA's general management focus will help me understand the driving forces in the industry and what can be done about... View Details